Literature DB >> 17942964

Mineral metabolism and vascular damage in children on dialysis.

Rukshana C Shroff1, Ann E Donald, Melanie P Hiorns, Alan Watson, Sally Feather, David Milford, Elizabeth A Ellins, Clare Storry, Deborah Ridout, John Deanfield, Lesley Rees.   

Abstract

Cardiovascular disease is increasingly recognized as a life-limiting problem in young patients with chronic kidney disease, but there are few studies in children that describe its determinants. We studied the association of intact parathyroid hormone (iPTH) levels and their management on vascular structure and function in 85 children, ages 5-18 years, who had received dialysis for > or =6 months. Compared to controls, dialysis patients had increased carotid intima-media thickness and pulse-wave velocity. All vascular measures positively correlated with serum phosphorus levels, while carotid intima-media thickness and cardiac calcification score also correlated with iPTH levels. Patients with mean time-integrated iPTH levels less than twice the upper limit of normal (n = 41) had vascular measures that were comparable to age-matched controls, but those with iPTH levels greater than twice the upper limit of normal (n = 44) had greater carotid intima-media thickness, stiffer vessels, and increased cardiac calcification than controls. Patients with increased carotid intima-media thickness had stiffer vessels and a greater prevalence of cardiac calcification. There was a strong dose-dependent correlation between vitamin D and all vascular measures, and calcium intake from phosphate binders weakly correlated with carotid intima-media thickness. In conclusion, both iPTH level and dosage of vitamin D are associated with vascular damage and calcification in children on dialysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942964     DOI: 10.1681/ASN.2006121397

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  83 in total

Review 1.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

2.  Can dialysis modality influence cardiovascular outcome?

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

Review 3.  Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies.

Authors:  Christophe Lamotte; Catalina Iliescu; Christian Libersa; Frédéric Gottrand
Journal:  Eur J Pediatr       Date:  2010-10-27       Impact factor: 3.183

4.  The vascular phenotype of children with systemic lupus erythematosus.

Authors:  Catherine Quinlan; Jameela Kari; Clarissa Pilkington; John Deanfield; Rukshana Shroff; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-05-23       Impact factor: 3.714

5.  Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

Authors:  Rukshana C Shroff; Rosamund McNair; Jeremy N Skepper; Nichola Figg; Leon J Schurgers; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

6.  Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.

Authors:  Sahar Fathallah-Shaykh; Dorota Drozdz; Joseph Flynn; Randall Jenkins; Katherine Wesseling-Perry; Sarah J Swartz; Craig Wong; Beverly Accomando; Gerald F Cox; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2017-09-12       Impact factor: 3.714

7.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

Review 8.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

Review 9.  Cardiovascular risk assessment in children with chronic kidney disease.

Authors:  Rukshana Shroff; Arianna Dégi; Andrea Kerti; Eva Kis; Orsolya Cseprekál; Kálmán Tory; Attila J Szabó; George S Reusz
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

10.  What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence?

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.